Mesa Laboratories, Inc. MLAB
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 53.39% | 168.42% | -213.94% | 46.61% | -47.79% |
| Total Depreciation and Amortization | -1.49% | -1.83% | 0.61% | -2.29% | -1.81% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 27.82% | -60.38% | 70.96% | -7.86% | 725.15% |
| Change in Net Operating Assets | -444.27% | -25.53% | -12.40% | 182.31% | 31.48% |
| Cash from Operations | -72.20% | 5.54% | -25.55% | 128.10% | 334.34% |
| Capital Expenditure | 30.77% | -34.05% | 43.03% | 32.97% | -8.23% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 30.77% | -34.05% | 43.03% | 32.97% | -8.23% |
| Total Debt Issued | -100.00% | -- | -- | -100.00% | 823.81% |
| Total Debt Repaid | 38.86% | -27.02% | -69.07% | 91.60% | -1,290.66% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | 9.71% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.58% | 0.00% | 0.00% | -0.23% | -1.03% |
| Other Financing Activities | -- | -- | 507.94% | 86.83% | 82.99% |
| Cash from Financing | -17.30% | 33.38% | -61.05% | -24.13% | 6.46% |
| Foreign Exchange rate Adjustments | 152.27% | -47.31% | -47.15% | 403.85% | -106.93% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -322.54% | 284.03% | -123.93% | 1,098.02% | 85.82% |